Indegene IPO GMP History
Indegene IPO has been listed on May 13, 2024 at a listing price of ₹655, against the issue price of ₹452 — a gain of ₹203 (+44.91%). The GMP peaked at ₹300 on 12 May 2024 and reached a low of ₹230 on 7 May 2024. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Indegene IPO raised ₹1841.76 Cr. through its IPO at a price band of ₹430 to ₹452 per share, with a lot size of 33 shares. The IPO was open for subscription from 06 May 2024 to 08 May 2024.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 10 Nov, 6:38 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 12 May 2024 | ₹ 300 | ▲ | 66% | — | — |
| 11 May 2024 | ₹ 270 | — | 60% | — | — |
| 10 May 2024 | ₹ 270 | — | 60% | — | — |
| 09 May 2024 | ₹ 270 | — | 60% | — | — |
| 08 May 2024 | ₹ 270 | ▲ | 60% | — | — |
| 07 May 2024 | ₹ 230 | ▼ | 51% | — | — |
| 06 May 2024 | ₹ 240 | — | 53% | — | — |
Indegene IPO dates
Key dates from opening to listing. Today is 11 November.
- Open 06 May 2024
- Close 08 May 2024
- Allotment 09 May 2024
- Refund/credit 10 May 2024
- Listing 13 May 2024
Indegene IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹452 |
|---|---|
| GMP-based estimate (pre-listing) | ₹752 (+66.4%) |
| Listing gain / loss | +₹203 per share |
| Listing date | 13 May, 2024 |
| Actual listing price | ₹655 (+44.91%) |
Is Indegene IPO GMP reliable?
Grey market premium for Indegene IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Indegene IPO full review for a fundamentals-based assessment before making any grey market trades.
Indegene IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Indegene IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Indegene IPO
Indegene Limited was incorporated in India in 1998. It provides digital-led commercialisation services for biopharmaceutical, emerging biotech and medical device companies.
Its solutions help with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of products. It combines over two decades of healthcare domain expertise with its technology platforms.
As of 31 December 2023 it had 65 active clients, served from six operation hubs and 17 offices across North America, Europe and Asia. Its subsidiary DT Associates offers consulting under the DT Consulting brand. The company has no identifiable promoter.
The IPO was Rs 1,841.76 crore, with Rs 760.52 crore of fresh issue and Rs 1,081.24 crore of offer for sale by investors and other shareholders. Rs 391.34 crore was planned for repaying debt of its subsidiary ILSL Holdings and Rs 102.92 crore for capital expenditure.
Frequently asked
What is the GMP of Indegene IPO?
The current Grey Market Premium (GMP) of Indegene IPO is ₹ 300.
What is the Kostak Price of Indegene IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Indegene IPO is not available.
What is the Subject to Sauda Price of Indegene IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Indegene IPO?
Indegene IPO listed on May 13, 2024 at ₹655, against the issue price of ₹452 — a gain of +44.91%.
How did the GMP of Indegene IPO trend before listing?
The GMP of Indegene IPO was rising in its final days before listing. The GMP peaked at ₹300 on 12 May 2024. View the day-wise table above for the complete GMP history.
Explore Indegene IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
